Previous 10 | Next 10 |
2024-06-25 06:45:00 ET Summary Alnylam has been extremely persistent over the years in getting their RNA interference ideas developed and tested. That original RNAi therapy (patisiran) was directed towards neuropathy, but Alnylam has been hoping that such treatments would show ben...
2024-06-25 06:18:33 ET More on Pfizer Pfizer: Seriously Undervalued At Peak Pessimism Pfizer Stock: The Reversal Should Keep Going Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Lilly, Novo Nordisk to dominate weight loss therapy marke...
2024-06-24 11:37:31 ET Summary HELIOS-B Phase III study of Amvuttra in patients with ATTR-CM succeeded across all metrics, showing significant benefits in both the combined study population and monotherapy groups. Amvuttra showed strong efficacy in reducing all-cause mortality and...
2024-06-23 14:00:00 ET More on Eli Lilly, Novo Nordisk Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity SA Asks: Who will launch the next big weight-loss drug? SA Asks: Is Eli Lilly or Novo No...
2024-06-23 12:49:01 ET More on the markets SPY: The Upside Is Likely Capped SPY: Rating Downgrade Due To Overvaluation Perfect Time For November Election Protection S&P posts three-week win streak, but momentum stalls after hitting 5,500 points mark ...
2024-06-23 11:13:33 ET Summary Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically received by Wall Street. On June 14, 2024, the c...
2024-06-23 05:42:00 ET Would you like to widen the stream of passive income you can expect each year? Managing rental property is an option, but most retirees find this method less passive than they would like it to be. Investors who are attracted to truly passive income generation may ...
2024-06-22 09:30:00 ET Summary We go over the importance of a DGI portfolio for income investors and retirees. We outline a simple process of selecting 15-20 individual dividend stocks for long-term growth, income, and lower volatility. In the end, we present a 15-stock DGI po...
2024-06-22 06:03:00 ET Investors looking for high-yield dividend stocks to buy now should turn their attention toward the healthcare sector: Three relatively reliable drugmakers are trading near their 52-week lows. Their stock prices may have been beaten down, but it's more than likely ...
2024-06-21 16:51:47 ET Summary Schwab U.S. Dividend Equity ETF™ is a conservative fund that offers stable growth and dividend growth, not suitable for high-growth or high-yield investors. It is too boring for you. The SCHD ETF holds 103 diversified holdings, with the top se...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...